Akèy › Kansè poumon › Connecticut › Hartford
Etid klinik pou Kansè poumon nan Hartford, CT
11 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Hartford (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Hartford Hospital, Hartford
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
- ak 1 plis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Hartford Hospital, Hartford
- Hartford HealthCare - Avon, Avon · 8 mi lwen
- Hartford HealthCare - Manchester, Manchester · 8 mi lwen
- ak 1 plis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Hartford Hospital, Hartford
Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi lwen
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Ap rekriteFaz 1/2
- Hartford Hospital (site 210), Hartford
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Hartford
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Ap rekriteEtid obsèvasyon
- Trinity Health Of New England, Hartford
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Hartford
- Kansè Poumon ki pa ti selil12 etid
- Twoub depresif majè9 etid
- Kansè (tout kalite)9 etid
- Kansè nan tete9 etid
- Neuroblastom8 etid
- Myelom Miltip7 etid
- Kansè pankreyas7 etid
- Kansè pwostat7 etid
- Kansè ovè7 etid
- Maladi kadyovaskilè7 etid
- Ensifizyans kadyak7 etid
- Maladi selil fòs5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.